WTW Stock Analysis: Willis Towers Watson | NASDAQ
Insurance Brokers | NASDAQ, USA | Market Cap: 27.873m USD | 12M Return: -1% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 155M
EPS Trend: 95.3%
Qual. Beats: 0
Rev. Trend: 81.3%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Willis Towers Watson (NASDAQ: WTW) is a London-based global advisory, broking, and solutions firm serving clients across two reportable segments: Health, Wealth & Career and Risk & Broking. The company provides strategy and design consulting, plan administration, actuarial support, and broking services for group benefits, pension, and retirement savings programs, as well as advice and software addressing total rewards and talent management.
In its Risk & Broking segment, WTW delivers insurance brokerage, risk advisory, and consulting across a wide range of specialty lines including property and casualty, aerospace, marine, natural resources, financial lines, and crisis management. The firm also offers technology, financial and regulatory reporting, capital modeling, M&A advisory, and business outsourcing services, reflecting the broader shift among large brokers toward integrated advisory platforms that combine consulting, brokerage commissions, and outsourced administration revenue.
Founded in 1828 and domiciled in the United Kingdom, the company was previously known as Willis Group Holdings and adopted its current name in January 2016. WTW is classified under the GICS Financials sector within the Multi-line Insurance sub-industry, and it trades on NASDAQ as a large-cap stock with origins in the London professional services market.
- Risk & Broking commissions rise on hard commercial insurance pricing
- Health and Benefits consulting grows amid employer benefit spending
- Share buybacks and dividends support capital return to shareholders
| Net Income: 1.67b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.10 > 1.0 |
| NWC/Revenue: 25.64% < 20% (prev 21.17%; Δ 4.48% < -1%) |
| CFO/TA 0.06 > 3% & CFO 1.80b > Net Income 1.67b |
| Net Debt (5.65b) to EBITDA (2.69b): 2.10 < 3 |
| Current Ratio: 1.19 > 1.5 & < 3 |
| Outstanding Shares: last quarter (95.8m) vs 12m ago -5.14% < -2% |
| Gross Margin: 38.16% > 18% (prev 44.11%; Δ -5.95% > 0.5%) |
| Asset Turnover: 34.30% > 50% (prev 34.96%; Δ -0.66% > 0%) |
| Interest Coverage Ratio: 8.51 > 6 (EBIT TTM 2.31b / Interest Expense TTM 272.0m) |
| A: 0.09 (Total Current Assets 16.1b - Total Current Liabilities 13.5b) / Total Assets 29.6b |
| B: -0.01 (Retained Earnings -392.0m / Total Assets 29.6b) |
| C: 0.08 (EBIT TTM 2.31b / Avg Total Assets 28.9b) |
| D: 0.37 (Book Value of Equity 7.98b / Total Liabilities 21.6b) |
| Altman-Z'' = 1.45 = BB |
| DSRI: 1.11 (Receivables 2.65b/2.37b, Revenue 9.90b/9.81b) |
| GMI: 1.16 (GM 44.11% / 38.16%) |
| AQI: 1.02 (AQ_t 0.42 / AQ_t-1 0.41) |
| SGI: 1.01 (Revenue 9.90b / 9.81b) |
| TATA: -0.00 (NI 1.67b - CFO 1.80b) / TA 29.6b) |
| Beneish M = -2.77 (Cap -4..+1) = A |
As of July 29, 2026, the stock is trading at USD 302.64 with a total of 462,376 shares traded. Over the past week, the price has changed by +3.18%, over one month by +14.75%, over three months by +4.98% and over the past year by -0.95%.
Current recommended Stop Loss: 291.80 (which is 3.6% or 1.5 ATR below the current price).
Willis Towers Watson has received a consensus analysts rating of 4.11. Therefore, it is recommended to buy WTW.
- StrongBuy: 8
- Buy: 5
- Hold: 4
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 339.7 | 12.2% |
P/E Trailing = 17.3288
P/E Forward = 15.5521
P/S = 2.8163
P/B = 3.4941
P/EG = 1.08
Revenue TTM = 9.90b USD
EBIT TTM = 2.31b USD
EBITDA TTM = 2.69b USD
Long Term Debt = 6.30b USD (from longTermDebt, last quarter)
Short Term Debt = 117.0m USD (from shortTermDebt, last quarter)
Debt = 7.51b USD (from shortLongTermDebtTotal, last quarter) + Leases 602.0m
Net Debt = 5.65b USD (calculated: Debt 7.51b - CCE 1.85b)
Enterprise Value = 33.5b USD (27.9b + Debt 7.51b - CCE 1.85b)
Interest Coverage Ratio = 8.51 (Ebit TTM 2.31b / Interest Expense TTM 272.0m)
EV/FCF = 21.31x (Enterprise Value 33.5b / FCF TTM 1.57b)
FCF Yield = 4.69% (FCF TTM 1.57b / Enterprise Value 33.5b)
FCF Margin = 15.89% (FCF TTM 1.57b / Revenue TTM 9.90b)
Net Margin = 16.84% (Net Income TTM 1.67b / Revenue TTM 9.90b)
Gross Margin = 38.16% ((Revenue TTM 9.90b - Cost of Revenue TTM 6.12b) / Revenue TTM)
Gross Margin QoQ = 24.59% (prev 50.99%)
Tobins Q-Ratio = 1.13 (Enterprise Value 33.5b / Total Assets 29.6b)
Interest Expense / Debt = 3.62% (Interest Expense 272.0m / Debt 7.51b)
Taxrate = 16.13% (323.0m / 2.00b)
NOPAT = 1.94b (EBIT 2.31b * (1 - 16.13%))
Current Ratio = 1.19 (Total Current Assets 16.1b / Total Current Liabilities 13.5b)
Debt / Equity = 0.94 (Debt 7.51b / totalStockholderEquity, last quarter 7.98b)
Debt / EBITDA = 2.10 (Net Debt 5.65b / EBITDA 2.69b)
Debt / FCF = 3.59 (Net Debt 5.65b / FCF TTM 1.57b)
Total Stockholder Equity = 7.95b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.78% (Net Income 1.67b / Total Assets 29.6b)
RoE = 20.98% (Net Income TTM 1.67b / Total Stockholder Equity 7.95b)
RoCE = 16.24% (EBIT 2.31b / Capital Employed (Equity 7.95b + L.T.Debt 6.30b))
RoIC = 12.36% (NOPAT 1.94b / Invested Capital 15.7b)
WACC = 5.03% (E(27.9b)/V(35.4b) * Re(5.57%) + D(7.51b)/V(35.4b) * Rd(3.62%) * (1-Tc(0.16)))
Discount Rate = 5.57% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.04 | Cagr: -3.58%
[DCF] Terminal Value 76.39% ; FCFF base≈1.53b ; Y1≈1.63b ; Y5≈1.95b
[DCF] Fair Price = 257.7 (EV 30.0b - Net Debt 5.65b = Equity 24.3b / Shares 94.4m; r=8.35% [WACC [floored]]; 5y FCF grow 7.59% → 2.50% )
EPS Correlation: 95.26 | EPS CAGR: 10.82% | SUE: 0.59 | # QB: 0
Revenue Correlation: 81.25 | Revenue CAGR: 2.48% | SUE: -0.32 | # QB: 0
EPS current Quarter (2026-06-30): EPS=3.11 | Chg30d=-0.13% | Revisions=+22% | Analysts=21
EPS next Quarter (2026-09-30): EPS=3.57 | Chg30d=-0.10% | Revisions=+12% | Analysts=19
EPS current Year (2026-12-31): EPS=19.50 | Chg30d=-0.01% | Revisions=+12% | GrowthEPS=+14.2% | GrowthRev=+7.2%
EPS next Year (2027-12-31): EPS=22.17 | Chg30d=-0.10% | Revisions=+29% | GrowthEPS=+13.7% | GrowthRev=+5.4%
[Analyst] Revisions Ratio: +26% (up=13, down=7)